Lyell Immunopharma (LYEL) Shares Repurchased (2020)

Lyell Immunopharma's (LYEL) quarterly Shares Repurchased came in at $6000.0 in Q2 2020.

Lyell Immunopharma (LYEL) Shares Repurchased (2020) Analysis & Trends

Lyell Immunopharma has disclosed Shares Repurchased across 1 years of filings, most recently posting $6000.0 for Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 839,896.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 336.90 Mn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Lyell Immunopharma 295.11 Mn 295.11 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2020 6,000.00
Jun 30, 2020 6,000.00